Directing dendritic cell immunotherapy towards successful cancer treatment

Rachel Lubong-Sabado, Nina Bhardwaj

Research output: Contribution to journalReview articlepeer-review

100 Scopus citations


The use of dendritic cells (DCs) for tumor immunotherapy represents a powerful approach for harnessing the patient's own immune system to eliminate tumor cells. However, suboptimal conditions for generating potent immunostimulatory DCs, as well as the induction of tolerance and suppression mediated by the tumors and its microenvironment have contributed to limited success. Combining DC vaccines with new approaches that enhance immunogenicity and overcome the regulatory mechanisms underlying peripheral tolerance may be the key to achieving effective and durable anti-tumor immune responses that translate to better clinical outcomes.

Original languageEnglish
Pages (from-to)37-56
Number of pages20
Issue number1
StatePublished - Jan 2010
Externally publishedYes


  • Dendritic cell
  • Tumor immunotherapy
  • Vaccination


Dive into the research topics of 'Directing dendritic cell immunotherapy towards successful cancer treatment'. Together they form a unique fingerprint.

Cite this